3.5 Years of Insulin Therapy With Insulin Glargine Improves In Vivo Endothelial Function in Type 2 Diabetes
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Objective— To determine long-term effects of insulin glargine on vascular function in patients with type 2 diabetes. Methods and Results— A total of 49 in vivo endothelial function tests, intrabrachial artery infusions of endothelium-dependent (acetylcholine [ACh]) and endothelium-independent (sodium nitroprusside [SNP]) vasoactive agents, were performed in 11 patients with type 2 diabetes (age: 59±2 years; BMI: 29.7±0.9 kg/m 2 ; fasting plasma glucose: 226±14 mg/dL) and 16 matched normal subjects. The tests in the type 2 diabetic patients were performed before and after 6 months and 3.5 years of combination therapy with insulin glargine and metformin. A control group of type 2 diabetic patients not treated with insulin was studied twice at 6-month intervals. Before treatment, blood flow during infusions of low and high doses of ACh were significantly lower in the type 2 diabetic patients than in the normal subjects ( P =0.021 for ANOVA). In the patients with type 2 diabetes, blood flow during infusion of the low dose of ACh averaged 7.1±0.8 mL/dL per minute at baseline, 8.8±1.0 mL/dL per minute at 6 months (NS), and then increased compared with baseline by 87±29% to 11.6±1.4 mL/dL per minute at 3.5 years ( P <0.02 versus baseline). Blood flow during infusion of the high dose of ACh increased from 8.8±0.9 at baseline to 13.0±1.9 mL/dL per minute at 6 months ( P <0.05) and by 86±25% to 14.7±1.6 mL/dL per minute at 3.5 years ( P <0.01 versus baseline), which was not different from normal subjects. Blood flow during infusion of low (blood flow at 0 months: 7.7±0.5; at 6 months: 9.9±0.6; P <0.01 for 6 versus 0 months; and 3.5 years: 11.6±1.1 mL/dL per minute; P <0.02 for 3.5 years versus 0 months) and high (blood flow at 0 months: 10.7±0.9; 6 months: 13.4±1.0; P <0.05 for 6 versus 0 months; and 3.5 years: 16.6±1.5 mL/dL per minute; P <0.05 for 3.5 years versus 0 months) doses of SNP also increased significantly during insulin therapy. Conclusions— We conclude that insulin glargine therapy improves endothelium-dependent and endothelium-independent vasodilatation. These data support the idea that long-term insulin therapy has beneficial rather than harmful effects on vascular function in type 2 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Heitzer, T., Schlinzig, T., Krohn, K., Meinertz, T., & Münzel, T. (2001) · Circulation · doi:10.1161/hc4601.099485 · Cited by 1,961
Malmberg, K. (1997) · BMJ · doi:10.1136/bmj.314.7093.1512 · Cited by 1,286
Prognostic Significance of Endothelial Dysfunction in Hypertensive Patients
Perticone, F., Ceravolo, R., Pujia, A., Ventura, G., Iacopino, S., Scozzafava, A., Ferraro, A., Chello, M., Mastroroberto, P., Verdecchia, P., et al. (2001) · Circulation · doi:10.1161/01.cir.104.2.191 · Cited by 1,059
Du, X. L., Edelstein, D., Dimmeler, S., Ju, Q., Sui, C., & Brownlee, M. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11235 · Cited by 907
Zeng, G., Nystrom, F. H., Ravichandran, L. V., Cong, L.-N., Kirby, M., Mostowski, H., & Quon, M. J. (2000) · Circulation · doi:10.1161/01.cir.101.13.1539 · Cited by 745
Kurtzhals, P., Schäffer, L., Sørensen, A., Kristensen, C., Jonassen, I., Schmid, C., & Trüb, T. (2000) · Diabetes · doi:10.2337/diabetes.49.6.999 · Cited by 739
Zeng, G., & Quon, M. J. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118871 · Cited by 726
Cited by
Basal insulin and cardiovascular and other outcomes in dysglycemia
The ORIGIN Trial Investigators (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1203858 · Cited by 1,636
Kolluru, G. K., Bir, S. C., & Kevil, C. G. (2012) · International Journal of Vascular Medicine · doi:10.1155/2012/918267 · Cited by 720
Krentz, A. J., Clough, G., & Byrne, C. D. (2007) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2007.00670.x · Cited by 168
Gill, J. M. R., Al-Mamari, A., Ferrell, W. R., Cleland, S. J., Packard, C. J., Sattar, N., Petrie, J. R., & Caslake, M. J. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.09.035 · Cited by 142
Gurkan, E., Tarkun, I., Sahin, T., Cetinarslan, B., & Canturk, Z. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.09.046 · Cited by 38
Metadata
- Authors
- Vehkavaara, S., & Yki-Järvinen, H.
- Venue
- Arteriosclerosis, Thrombosis, and Vascular Biology
- Published
- 2004-02
- Volume
- 24
- Issue
- 2
- Pages
- 325-330
- ISSN
- 1079-5642 (ISSN-L)
- 1524-4636
- OpenAlex
- W2124844858
- Cited by
- 76
- References
- 7
- FWCI
- 3.77
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: 3.5 Years of Insulin Therapy With Insulin Glargine Improves In Vivo Endothelial Function in Type 2 Diabetes. https://app.cochat.ai/papers/10.1161/01.atv.0000113817.48983.c5
- The paper
- Vehkavaara, S., & Yki-Järvinen, H. (2004). 3.5 Years of Insulin Therapy With Insulin Glargine Improves In Vivo Endothelial Function in Type 2 Diabetes. Arteriosclerosis, Thrombosis, and Vascular Biology. https://doi.org/10.1161/01.atv.0000113817.48983.c5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.